Recombinant Human Growth Hormone (HGH) is a bioactive protein intended for use in cell culture applications. HGH is a hormone with multiple effects. HGH is a pleiotropic molecule that binds the GH receptor. Recombinant Human Growth Hormone (HGH) is one of our more than 250 available Gibco® recombinant proteins.
This report contains market size and forecasts of Recombinant Human Growth Hormone in global, including the following market information:
Global Recombinant Human Growth Hormone Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Human Growth Hormone Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Recombinant Human Growth Hormone companies in 2021 (%)
The global Recombinant Human Growth Hormone market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Human Growth Hormone include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono, F.Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen and LG Life Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Human Growth Hormone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Human Growth Hormone Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Recombinant Human Growth Hormone Market Segment Percentages, by Type, 2021 (%)
Powder
Solvent
Global Recombinant Human Growth Hormone Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Recombinant Human Growth Hormone Market Segment Percentages, by Application, 2021 (%)
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age
SHOX Deficiency
Others
Global Recombinant Human Growth Hormone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Recombinant Human Growth Hormone Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Human Growth Hormone revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Human Growth Hormone revenues share in global market, 2021 (%)
Key companies Recombinant Human Growth Hormone sales in global market, 2017-2022 (Estimated), (MT)
Key companies Recombinant Human Growth Hormone sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F.Hoffmann-La Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
BioPartners